CryoPort (CYRX)
(Delayed Data from NSDQ)
$14.05 USD
+0.61 (4.54%)
Updated May 15, 2024 04:00 PM ET
After-Market: $14.06 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$14.05 USD
+0.61 (4.54%)
Updated May 15, 2024 04:00 PM ET
After-Market: $14.06 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Zacks News
Schneider National (SNDR) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Schneider National (SNDR) delivered earnings and revenue surprises of 5.88% and 4.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -55% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
New Strong Sell Stocks for March 10th
by Zacks Equity Research
BSET, CYRX, and DIN have been added to the Zacks Rank #5 (Strong Sell) List on March 10, 2022.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -780% and 2.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Here's Why CryoPort, Inc. (CYRX) is Poised for a Turnaround After Losing 22.8% in 4 Weeks
by Zacks Equity Research
CryoPort, Inc. (CYRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Expeditors International (EXPD) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Expeditors International (EXPD) delivered earnings and revenue surprises of 31.68% and 26.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
CryoPort, Inc. (CYRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Forward Air (FWRD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Forward Air (FWRD) delivered earnings and revenue surprises of 9.38% and 4.74%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -20.00% and 3.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
CryoPort, Inc. (CYRX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
by Zacks Equity Research
CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -23.08% and 9.69%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
CryoPort, Inc. (CYRX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
by Zacks Equity Research
CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cryoport (CYRX) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Cryoport (CYRX) has been struggling lately, but the selling pressure may be coming to an end soon.
4 Sector ETFs & Stocks to Play U.S. June Inflation Data
by Sanghamitra Saha
Annual inflation rate in the United States accelerated to 5.4% year over year in June of 2021 from 5% in May.
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of 38.10% and 13.63%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -86.67% and 11.71%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Chart Industries to Divest Cryobiological Product Business
by Zacks Equity Research
The divestment of Chart Industries' (GTLS) cryobiological products business will likely help it focus on high-growth opportunities in clean energy and debt repayment.
Cryoport (CYRX) Catches Eye: Stock Jumps 9.8%
by Zacks Equity Research
Cryoport (CYRX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Company News for Aug 24, 2020
by Zacks Equity Research
Companies in the news are: DE, FL, GASS, CYRX
New Strong Sell Stocks for July 28th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today